In vitro inhibition of the replication of classical swine fever virus by capsid-targeted virus inactivation

Antiviral Research

Volumn 85, Issue 2, 2010, Pages 422-424

  Wang, Yu Fei ^a   Wang, Zhong Hua ^a   Li, Yan ^a   Zhang, Xing Juan ^a   Sun, Yuan ^a   Li, Miao ^a   Qiu, Hua Ji ^a  

^a Harbin Veterinary Research Institute   (China)

Author keywords

Antiviral strategy; Capsid targeted viral inactivation (CTVI); Classical swine fever virus; Protein transduction domain

Indexed keywords

CALCIUM ION; CAPSID PROTEIN STAPHYLOCOCCUS AUREUS NUCLEASE FUSION PROTEIN; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INACTIVATION; ESCHERICHIA COLI; IN VITRO STUDY; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; CAPSID; CAPSID PROTEINS; CELL LINE; CLASSICAL SWINE FEVER VIRUS; ESCHERICHIA COLI; GENE EXPRESSION; MICROCOCCAL NUCLEASE; RECOMBINANT FUSION PROTEINS; SWINE; VIRUS INACTIVATION; VIRUS REPLICATION;

CLASSICAL SWINE FEVER VIRUS; ESCHERICHIA COLI; MIRIDAE; STAPHYLOCOCCUS AUREUS; SUIDAE;

EID: 74449091319     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.10.010     Document Type: Article

References (23)

1. Beer M., Reimann I., Hoffmann B., and Depner K. Novel marker vaccines against classical swine fever. Vaccine 25 (2007) 5665-5670
2. Beterams G., and Nassal M. Significant interference with hepatitis B virus replication by a core-nuclease fusion protein. J. Biol. Chem. 276 (2001) 8875-8883
3. ICTV. The International Committee on Taxonomy of Viruses Online (2006). http://www.virustaxonomyonline.com/virtax/lpext.dll?f=templates&fn=main-h.htm
4. Liu J., Li Y.H., Xue C.F., Ding J., Gong W.D., Zhao Y., and Huang Y.X. Targeted ribonuclease can inhibit replication of hepatitis B virus. World J. Gastroenterol. 9 (2003) 295-299
5. Moennig V. Introduction to classical swine fever: virus, disease and control policy. Vet. Microbiol. 73 (2000) 93-102
6. Natsoulis G., and Boeke J.D. New antiviral strategy using capsid-nuclease fusion proteins. Nature 352 (1991) 632-635
7. Natsoulis G., Seshaiah P., Federspiel M.J., Rein A., Hughes S.H., and Boeke J.D. Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 364-368
8. Okui N., Kitamura Y., Kobayashi N., Sakuma R., Ishikawa T., and Kitamura T. Virion-targeted viral inactivation: new therapy against viral infection. Mol. Urol. 5 (2001) 59-66
9. OIE. Classical Swine Fever (Hog Cholera), Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Mammals, Birds and Bees). 5th ed. (2004), Office International des Epizooties, Paris, France pp. 244-252 [Part 2, Chapter 2.1.13]
10. Qin C.F., Qin E., Yu M., Chen S.P., Jiang T., Deng Y.Q., Duan H.Y., and Zhao H. Therapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures. Arch. Virol. 150 (2005) 659-669
11. Schumann G., Cannon K., Ma W.P., Crouch R.J., and Boeke J.D. Antiretroviral effect of a gag-RNase HI fusion gene. Gene Ther. 4 (1997) 593-599
12. Schumann G., Hermankova M., Cannon K., Mankowski J.L., and Boeke J.D. Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo. J. Virol. 75 (2001) 7030-7041
13. Schumann G., Qin L., Rein A., Natsoulis G., and Boeke J.D. Therapeutic effect of gag-nuclease fusion protein on retrovirus-infected cell cultures. J. Virol. 70 (1996) 4329-4337
14. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
15. Tucker P.W., Hazen Jr. E.E., and Cotton F.A. Staphylococcal nuclease reviewed: a prototypic study in contemporary enzymology. III. Correlation of the three-dimensional structure with the mechanisms of enzymatic action. Mol. Cell Biochem. 23 (1979) 67-86
16. VanBrocklin M., Ferris A.L., Hughes S.H., and Federspiel M.J. Expression of a murine leukemia virus Gag-Escherichia coli RNase HI fusion polyprotein significantly inhibits virus spread. J. Virol. 71 (1997) 3312-3318
17. VanBrocklin M., and Federspiel M.J. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro. Virology 267 (2000) 111-123
18. Vrancken R., Paeshuyse J., Haegeman A., Puerstinger G., Froeyen M., Herdewijn P., Kerkhofs P., Neyts J., and Koenen F. Imidazo[4,5-c]pyridines inhibit the in vitro replication of the classical swine fever virus and target the viral polymerase. Antiviral Res. 77 (2008) 114-119
19. Vrancken R., Haegeman A., Paeshuyse J., Puerstinger G., Rozenski J., Wright M., Tignon M., Le Potier M.F., Neyts J., and Koenen F. A proof of concept for the reduction of classical swine fever infection in pigs by a novel viral polymerase inhibitor. J. Gen. Virol. 90 (2009) 1335-1342
20. Weber D.J., Meeker A.K., and Mildvan A.S. Interactions of the acid and base catalysts on staphylococcal nuclease as studied in a double mutant. Biochemistry 30 (1991) 6103-6114
21. Wheeler D.S., Dunsmore K.D., and Wong H.R. Intracellular delivery of HSP70 using HIV-1 tat protein transduction domain. Biochem. Biophys. Res. Commun. 301 (2003) 54-59
22. Wu X., Liu H., Xiao H., Kim J., Seshaiah P., Natsoulis G., Boeke J.D., Hahn B.H., and Kappes J.C. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J. Virol. 69 (1995) 3389-3398
23. Zhao J.J., Cheng D., Li N., Sun Y., Shi Z., Zhu Q.H., Tu C., Tong G.Z., and Qiu H.J. Evaluation of a multiplex real-time RT-PCR for quantitative and differential detection of wild-type viruses and c-strain vaccine of classical swine fever virus. Vet. Microbiol. 126 (2008) 1-10